The Report
Deep dives into company funding, growth strategies, and market insights from the world's most innovative businesses
4 reports and counting
Insitro Raises $400M in Series D
Insitro, a Biotech company based in 279 East Grand Avenue, South San Francisco, CA 94080, has raised $400M in Series D at a $2.8B valuation led by Blackstone, Canada Pension Plan Investment Board, Arch Venture Partners, Foresite Capital, GV, Andreessen Horowitz.
Insitro raises $400M Series D at $2.8B valuation
Insitro raises $400M in Series D at $2.8B valuation. Machine learning for drug discovery...
Insitro Raises $400M Series C
Machine learning drug discovery company using data-driven approach to identify disease targets and develop therapeutics
Treeline Biosciences Raises $421 Million in Undisclosed Round - October 17, 2024
Treeline Biosciences announced $421 Million in Undisclosed Round funding at a $1.1 Billion+ Total Raised valuation. Treeline Biosciences is a secretive biotech company focused on developing innovative cancer therapeutics using AI-powered drug discovery platforms....
Showing 4 reports • Page 1 • Category: all
Stay ahead of the market
Get weekly insights delivered to your inbox. No spam, just intelligence.